| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85565339437cceb5981667ed85090e81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e351957e7d8e0007e3ed001d26a270d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a101999f5758133cc0dfd48862b09f6c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G21G2001-0042 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G21G1-0005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G21G1-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G21G1-00 |
| filingDate |
2011-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3da36a9e612d5781dd42e19aeea3baa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c8fe7f766dc0c7993eabca1beaf4488 |
| publicationDate |
2011-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011134672-A1 |
| titleOfInvention |
Isotope production method |
| abstract |
The present invention relates to a method for the generation of 223 Ra of pharmaceutically tolerable purity comprising: i) preparing a generator mixture comprising 227 Ac, 227 Th and 223 Ra in a first aqueous solution comprising a first mineral acid; ii) loading said generator mixture onto a DGA separation medium (e.g. resin); iii) eluting said 223 Ra from said DGA separation medium using a second mineral acid in a second aqueous solution to give an eluted 223 Ra solution; and iv) stripping the DGA separation medium of said 227 Ac and 227 Th by flowing a third mineral acid in a third aqueous solution through the DGA separation medium in a reversed direction; The invention further relates to high purity radium-223 formed or formable by such a method as well as pharmaceutical compositions comprising such radium-223 of pharmaceutical purity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017312535-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014095833-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018035020-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-306722-B6
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018153969-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016083739-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11380453-B2 |
| priorityDate |
2010-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |